WallachBeth Capital, LLC

Harborside Financial Plaza 5

185 Hudson St., Suite 1410

Jersey City, NJ 07311

 

August 25, 2022

 

VIA EDGAR CORRESPONDENCE

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Ms. Taylor Beech, Staff Attorney

 

Re:

bioAffinity Technologies, Inc.

Registration Statement on Form S-1

File No. 333-264463

 

WITHDRAWAL OF REQUEST FOR ACCELERATION OF EFFECTIVENESS

 

Dear Ms. Beech:

 

Reference is made to our letter, filed as correspondence via EDGAR on August 24, 2022, in which we requested the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 for 4:30 p.m., Eastern Time, on Thursday, August 25, 2022, in accordance with Rule 461 under the Securities Act of 1933, as amended.

 

We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of that effective date.

 

Please contact our counsel, Jeffrey Koeppel, Esq., of Carmel, Milazzo & Feil LLP, at (301) 785-4319 if you have any questions in this regard.

 

   Best Regards,
        
   WALLACHBETH CAPITAL, LLC
        
   By: /s/ Eric Schweitzer
   Name: Eric Schweitzer
   Title: Chief Compliance Officer